The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
The Role of Prolactin in Mammary Carcinoma
Open accessAbstract
The contribution of prolactin (PRL) to the pathogenesis and progression of human breast cancer at the cellular, transgenic, and epidemiological levels is increasingly appreciated. Acting at the endocrine and autocrine/paracrine levels, PRL functions to stimulate the growth and motility of human breast cancer cells. The actions of this ligand are mediated by at least six recognized PRL receptor isoforms found on, or secreted by, human breast epithelium. The PRL/PRL receptor complex associates with and activates several signaling networks that are shared with other members of the cytokine receptor superfamily. Coupled with the recently identified intranuclear function of PRL, these networks are integrated into the in vitro and in vivo actions induced by ligand. These findings indicate that antagonists of PRL/PRL receptor interaction or PRL receptor-associated signal transduction may be of considerable utility in the treatment of human breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Aoki, N., & Matsuda, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005615200 · Cited by 179
RetractedPatterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., & Kelly, P. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0334 · Cited by 1,938
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 2×
“of Stats 1 and 3 in primary mammary tumors (200, 201), and”
BackgroundTeglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., & Ihle, J. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81444-0 · Cited by 1,267
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status
Byrne, C., Schairer, C., Wolfe, J., Parekh, N., Salane, M., Brinton, L. A., Hoover, R., & Haile, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1622 · Cited by 864
Induction of NF-κB by the Akt/PKB kinase
Kane, L. P., Shapiro, V. S., Stokoe, D., & Weiss, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80265-6 · Cited by 846
Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.
Ormandy, C. J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H., Edery, M., Brousse, N., Babinet, C., Binart, N., et al. (1997) · Genes & Development · doi:10.1101/gad.11.2.167 · Cited by 808
Inhibition of Stat1-mediated gene activation by PIAS1
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., & Shuai, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10626 · Cited by 765
Risk for breast cancer development determined by mammographic parenchymal pattern
Wolfe, J. N. (1976) · Cancer · doi:10.1002/1097-0142(197605)37:5<2486::aid-cncr2820370542>3.0.co;2-8 · Cited by 750
Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects*
BEN-JONATHAN, N., MERSHON, J. L., ALLEN, D. L., & STEINMETZ, R. W. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-639 · Cited by 734
Endogenous Hormones and Breast Cancer Risk
Bernstein, L., & Ross, R. K. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036116 · Cited by 691
Hahnfeldt, P., Panigrahy, D., Folkman, J., & Hlatky, L. (1999) · PubMed · Cited by 662
Horseman, N. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6926 · Cited by 650
Haemopoietic receptors and helical cytokines
Bazan, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 638
Differentiation of the mammary gland and susceptibility to carcinogenesis
Russo, J., Tay, L. K., & Russo, I. H. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805718 · Cited by 629
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 598
TANAKA, T., SHIU, R. P. C., GOUT, P. W., BEER, C. T., NOBLE, R. L., & FRIESEN, H. G. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1058 · Cited by 571
Kirchhausen, T. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.699 · Cited by 560
Alcohol, Height, and Adiposity in Relation to Estrogen and Prolactin Levels in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Manson, J. E., Hunter, D. J., Colditz, G. A., Stampfer, M. J., Longcope, C., & Speizer, F. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.17.1297 · Cited by 560
Self-citationLiu, X., Robinson, G. W., Gouilleux, F., Groner, B., & Hennighausen, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8831 · Cited by 557
Phosphoinositide 3-kinase signalling pathways
Cantrell, D. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1439 · Cited by 533
Cre-mediated gene deletion in the mammary gland
Wagner, K.-U., Wall, R. J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., Li, M., Furth, P. A., & Hennighausen, L. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4323 · Cited by 518
Self-citationMuise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W., & Groner, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03048.x · Cited by 504
Welsch, C. W. (1985) · PubMed · Cited by 492
Janus kinases: components of multiple signaling pathways
Rane, S. G., & Reddy, E. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203925 · Cited by 466
Prolactin and murine mammary tumorigenesis: a review.
Welsch, C. W., & Nagasawa, H. (1977) · PubMed · Cited by 466
SOCS: physiological suppressors of cytokine signaling
Krebs, D. L., & Hilton, D. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2813 · Cited by 463
Integrating the MAP kinase signal into the G1 phase cell cycle machinery
Roovers, K., & Assoian, R. K. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<818::aid-bies7>3.0.co;2-6 · Cited by 458
van Landeghem, A. A. J., Poortman, J., Nabuurs, M., & Thijssen, J. H. H. (1985) · PubMed · Cited by 448
Phosphoinositide 3-kinase signalling pathways
Domin, J. (2006) · Phosphoinositide 3-Kinase Signalling Pathway · doi:10.1142/9781860948091_0003 · Cited by 444
Structural Variants of Prolactin: Occurrence and Physiological Significance
SINHA, Y. N. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-354 · Cited by 433
Signaling Pathways in Mammary Gland Development
Hennighausen, L., & Robinson, G. W. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00064-8 · Cited by 422
Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-484_1 · Cited by 413
Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression
Gille, H., & Downward, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.22033 · Cited by 409
National Cancer Institute (2020) · Definitions · doi:10.32388/f3vp5p · Cited by 383
Li, M., Liu, X., Robinson, G., Bar-Peled, U., Wagner, K.-U., Young, W. S., Hennighausen, L., & Furth, P. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3425 · Cited by 375
Self-citationErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases
Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., & Hynes, N. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17209 · Cited by 367
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.
Hankinson, S. E., Manson, J. E., Spiegelman, D. L., Willett, W. C., Longcope, C., & Speizer, F. E. (1995) · PubMed · Cited by 361
Self-citationThe 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Prolactin Controls Mammary Gland Development via Direct and Indirect Mechanisms
Brisken, C., Kaur, S., Chavarria, T. E., Binart, N., Sutherland, R. L., Weinberg, R. A., Kelly, P. A., & Ormandy, C. J. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9271 · Cited by 339
Matsumura, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1367 · Cited by 332
Danielson, K. G., Oborn, C. J., Durban, E. M., Butel, J. S., & Medina, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3756 · Cited by 331
Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas.
Gout, P. W., Beer, C. T., & NOBLE, R. L. (1980) · PubMed · Cited by 310
Protein Kinases as Mediators of Phosphoinositide 3-Kinase Signaling
Toker, A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26463-4 · Cited by 304
Null Mutation of the Prolactin Receptor Gene Produces a Defect in Maternal Behavior
Lucas, B. K., Ormandy, C. J., Binart, N., Bridges, R. S., & Kelly, P. A. (1998) · Endocrinology · doi:10.1210/en.139.10.4102 · Cited by 297
Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Michaud, D. S., Manson, J. E., Colditz, G. A., Longcope, C., Rosner, B., & Speizer, F. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.629 · Cited by 297
Self-citationVerkasalo, P. K., Thomas, H. V., Appleby, P. N., Davey, G. K., & Key, T. J. (2001) · Cancer Causes & Control · doi:10.1023/a:1008929714862 · Cited by 287
Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 280
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D’Angelo, G., Goffin, V., Weiner, R. I., & Martial, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1246 · Cited by 279
Miyoshi, K., Shillingford, J. M., Smith, G. H., Grimm, S. L., Wagner, K.-U., Oka, T., Rosen, J. M., Robinson, G. W., & Hennighausen, L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200107065 · Cited by 278
Experimentally induced mammary tumors in rats
Russo, J., & Russo, I. H. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806074 · Cited by 267
Boutin, J.-M., Edery, M., Shirota, M., Jolicoeur, C., Lesueur, L., Ali, S., Gould, D., Djiane, J., & Kelly, P. A. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-9-1455 · Cited by 266
Matsumoto, A., Seki, Y., Kubo, M., Ohtsuka, S., Suzuki, A., Hayashi, I., Tsuji, K., Nakahata, T., Okabe, M., Yamada, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6396 · Cited by 266
Ahn, S., Maudsley, S., Luttrell, L. M., Lefkowitz, R. J., & Daaka, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1185 · Cited by 263
Prolactin synthesis and secretion by human breast cancer cells.
Ginsburg, E., & Vonderhaar, B. (1995) · PubMed · Cited by 260
Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., & Yang, C. H. (1997) · Science · doi:10.1126/science.276.5317.1418 · Cited by 258
Apter, D., Reinilä, M., & Vihko, R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440506 · Cited by 256
Regression calibration method for correcting measurement-error bias in nutritional epidemiology
Spiegelman, D., McDermott, A., & Rosner, B. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1179s · Cited by 254
Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L., Montone, K. T., & Tomaszewski, J. E. (1995) · PubMed Central · Cited by 252
Self-citationDoppler, W., Groner, B., & Ball, R. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.104 · Cited by 251
Gellersen, B. (1994) · Molecular Endocrinology · doi:10.1210/me.8.3.356 · Cited by 249
Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
Jackson, D., Volpert, O., Bouck, N., & Linzer, D. (1994) · Science · doi:10.1126/science.7527157 · Cited by 247
Expression of Multiple Forms of the Prolactin Receptor in Mouse Liver
Davis, J. A., & Linzer, D. I. H. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-4-674 · Cited by 235
Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer
Yee, D., & Lee, A. V. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009575518338 · Cited by 234
Schmid, R.-S., Pruitt, W. M., & Maness, P. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04177.2000 · Cited by 230
Watson, C., & Miller, W. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.162 · Cited by 226
Ross, R. J. M. (1997) · Molecular Endocrinology · doi:10.1210/me.11.3.265 · Cited by 222
BAUMANN, G., AMBURN, K. D., & BUCHANAN, T. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-657 · Cited by 222
Campbell, G. S., Argetsinger, L. S., Ihle, J. N., Kelly, P. A., Rillema, J. A., & Carter-Su, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5232 · Cited by 221
Lebrun, J. J., Ali, S., Sofer, L., Ullrich, A., & Kelly, P. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36749-2 · Cited by 220
Serum Estradiol Level and Risk of Breast Cancer During Treatment With Raloxifene
Cummings, S. R. (2002) · JAMA · doi:10.1001/jama.287.2.216 · Cited by 219
FERRARA, N., CLAPP, C., & WEINER, R. (1991) · Endocrinology · doi:10.1210/endo-129-2-896 · Cited by 212
Sex hormones in women in rural China and in Britain
Key, T., Chen, J., Wang, D., Pike, M., & Boreham, J. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.344 · Cited by 210
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest, P. J., Michalides, R. J. A. M., Jannink, L., van der Valk, P., Peterse, H. L., de Jong, J. S., Meijer, C. J. L. M., & Baak, J. P. A. (1997) · Europe PMC (PubMed Central) · Cited by 207
Wennbo, H., Gebre-Medhin, M., Gritli-Linde, A., Ohlsson, C., Isaksson, O. G., & Törnell, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119820 · Cited by 207
RESERPINE USE IN RELATION TO BREAST CANCER
Heinonen, O. P., Shapiro, S., Tuominen, L., & Turunen, M. I. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93259-0 · Cited by 205
Long-Term Effect of a First Pregnancy on the Secretion of Prolactin
Musey, V. C., Collins, D. C., Musey, P. I., Martino-Saltzman, D., & Preedy, J. R. K. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701293160501 · Cited by 204
Increased incidence of neoplasia in patients with pituitary adenomas
Popovic, V., Damjanovic, S., Micic, D., Nesovic, M., Djurovic, M., Petakov, M., Obradovic, S., Zoric, S., Simic, M., Penezic, Z., et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00536.x · Cited by 196
Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling
Pezet, A., Favre, H., Kelly, P. A., & Edery, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24497 · Cited by 196
Expression of Prolactin and Its Receptor in Human Breast Carcinoma1
Reynolds, C., Montone, K. T., Powell, C. M., Tomaszewski, J. E., & Clevenger, C. V. (1997) · Endocrinology · doi:10.1210/endo.138.12.5605 · Cited by 194
Self-citationPhosphatidylinositol 3‐kinases in tumor progression
Roymans, D., & Slegers, H. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01936.x · Cited by 192
The ubiquitin-proteasome system and endocytosis
Strous, G. J., & Govers, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.10.1417 · Cited by 189
Sartor, C. I., Dziubinski, M. L., Yu, C., Jove, R., & Ethier, S. P. (1997) · PubMed · Cited by 184
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor.
Ali, S., Pellegrini, I., & Kelly, P. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54897-3 · Cited by 183
Convergence of Progesterone with Growth Factor and Cytokine Signaling in Breast Cancer
Richer, J. K., Lange, C. A., Manning, N. G., Owen, G., Powell, R., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31317 · Cited by 181
Lange, C. A., Richer, J. K., & Horwitz, K. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0290 · Cited by 181
Regions of the JAK2 Tyrosine Kinase Required for Coupling to the Growth Hormone Receptor
Frank, S. J., Yi, W., Zhao, Y., Goldsmith, J. F., Gilliland, G., Jiang, J., Sakai, I., & Kraft, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14776 · Cited by 178
DaSilva, L., Rui, H., Erwin, R. A., Zack Howard, O. M., Kirken, R. A., Malabarba, M. G., Hackett, R. H., Larner, A. C., & Farrar, W. L. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03738-1 · Cited by 175
A prospective study of endogenous hormones and breast cancer.
Kj, H., Aj, A., Tl, B., Longcope, C., Gb, G., & Comstock, G. W. (1994) · PubMed · Cited by 170
Mammary gland involution is delayed by activated Akt in transgenic mice
Schwertfeger, K. L., Richert, M. M., & Anderson, S. M. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.6.0663 · Cited by 169
Yamauchi, T., Kaburagi, Y., Ueki, K., Tsuji, Y., Stark, G. R., Kerr, I. M., Tsushima, T., Akanuma, Y., Komuro, I., Tobe, K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15719 · Cited by 169
Clapp, C., & Weiner, R. I. (1992) · Endocrinology · doi:10.1210/endo.130.3.1311239 · Cited by 167
Clevenger, C. V. (1994) · Molecular Endocrinology · doi:10.1210/me.8.6.674 · Cited by 167
Self-citationLebrun, J.-J., Ali, S., Ullrich, A., & Kelly, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10664 · Cited by 165
Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity
Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., Krolewski, J. J., Medveczky, P., & Jove, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002383200 · Cited by 164
PRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway
Brockman, J. L. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.774 · Cited by 163
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer
Rycyzyn, M. A., & Clevenger, C. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092160699 · Cited by 160
Self-citationCarroll, J. S., Prall, O. W. J., Musgrove, E. A., & Sutherland, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004424200 · Cited by 158
A prospective study of estradiol and breast cancer in Japanese women.
Kabuto, M., Akiba, S., Stevens, R. G., Neriishi, K., & Land, C. E. (2000) · PubMed · Cited by 156
Dupont, J., Karas, M., & LeRoith, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006741200 · Cited by 155
Requirement of Nuclear Prolactin for Interleukin-2—Stimulated Proliferation of T Lymphocytes
Clevenger, C. V., Altmann, S. W., & Prystowsky, M. B. (1991) · Science · doi:10.1126/science.2063207 · Cited by 151
Self-citationRecognition of sorting signals by clathrin adaptors
Heilker, R., Spiess, M., & Crottet, P. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199907)21:7<558::aid-bies4>3.0.co;2-r · Cited by 150
DaSilva, L., Howard, O. M. Z., Rui, H., Kirken, R. A., & Farrar, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32296-2 · Cited by 143
The effect of contraceptive steroids on hypothalamic-pituitary function
Mishell, D. R., Kletzky, O. A., Brenner, P. F., Roy, S., & Nicoloff, J. T. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90295-2 · Cited by 141
PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation.
Ali, S., Chen, Z., Lebrun, J. J., Vogel, W. F., Kharitonenkov, A., Kelly, P. A., & Ullrich, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00341.x · Cited by 140
Yamashita, H., Xu, J., Erwin, R. A., Farrar, W. L., Kirken, R. A., & Rui, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30218 · Cited by 140
Zhao, Y., Wagner, F. H., Frank, S. J., & Kraft, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13814 · Cited by 140
Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor
Kline, J. B., Roehrs, H., & Clevenger, C. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35461 · Cited by 137
Self-citationProlactin receptor signal transduction in cells of the immune system
Clevenger, C., Freier, D., & Kline, J. B. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1570187 · Cited by 132
Self-citationJAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization
Rui, H., Lebrun, J. J., Kirken, R. A., Kelly, P. A., & Farrar, W. L. (1994) · Endocrinology · doi:10.1210/en.135.4.1299 · Cited by 131
Detection of Endogenous Immunoreactive Prolactin in Rat Mammary Epithelial Cells During Lactation11
Nolin, J. M., & Witorsch, R. J. (1976) · Endocrinology · doi:10.1210/endo-99-4-949 · Cited by 131
Prolactin and Mammary Gland Development
Horseman, N. D. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018708704335 · Cited by 130
Hankinson, S. E., Colditz, G. A., Hunter, D. J., Manson, J. E., Willett, W. C., Stampfer, M. J., Longcope, C., & Speizer, F. E. (1995) · Cancer Causes & Control · doi:10.1007/bf00051793 · Cited by 129
Self-citationProlactin Receptor Antagonists That Inhibit the Growth of Breast Cancer Cell Lines
Fuh, G., & Wells, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13133 · Cited by 128
Elevated Serum Levels of Estrogen and Prolactin in Daughters of Patients with Breast Cancer
Henderson, B. E., Gerkins, V. R., Rosario, I., Casagrande, J. T., & Pike, M. C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931602 · Cited by 128
Receptor-mediated nuclear translocation of growth hormone.
Lobie, P. E., Mertani, H. C., Morel, G., Morales-Bustos, O., Norstedt, G., & Waters, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31966-x · Cited by 125
Prolactin receptor signal transduction
Clevenger, C. V., & Kline, J. B. (2001) · Lupus · doi:10.1191/096120301717164949 · Cited by 125
Self-citationEfficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
McMurray, R. W., Weidensaul, D., Allen, S. H., et al. (1995) · PubMed · Cited by 123
Goffin, V., Kinet, S., Ferrag, F., Binart, N., MARTIAL, J. A., & Kelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16573 · Cited by 122
Activation ofraf-1, MEK, and MAP kinase in prolactin responsive mammary cells
Das, R., & Vonderhaar, B. K. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806209 · Cited by 120
Humphreys, R. C., & Hennighausen, L. G. (1999) · PubMed · Cited by 119
Clevenger, C. V., Torigoe, T., & Reed, J. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37498-7 · Cited by 114
Self-citationReserpine and Breast Cancer in a Retirement Community
Mack, T. M., Henderson, B. E., Gerkins, V. R., Arthur, M., Baptista, J., & Pike, M. C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197506262922603 · Cited by 114
Kazansky, A. V., Kabotyanski, E. B., Wyszomierski, S. L., Mancini, M. A., & Rosen, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22484 · Cited by 113
Lecoq‐Lafon, C., Verdier, F., Fichelson, S., Chrétien, S., Gisselbrecht, S., Lacombe, C., & Mayeux, P. (1999) · Blood · doi:10.1182/blood.v93.8.2578 · Cited by 113
Holly, J., Gunnell, D., & Smith, G. D. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620321 · Cited by 111
Taverna, D., Groner, B., & Hynes, N. E. (1991) · PubMed · Cited by 110
Ormandy, C. J., Hall, R. E., Manning, D. L., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4361 · Cited by 110
Loss of Stat5a delays mammary cancer progression in a mouse model
Ren, S. V., Cai, H. R., Li, M., & Furth, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205484 · Cited by 109
Self-citationDivergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
Levy, D. E., & Gilliland, D. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203480 · Cited by 108
Clevenger, C. V., Ngo, W., Sokol, D. L., Luger, S. M., & Gewirtz, A. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13246 · Cited by 107
Self-citationLindeman, G., Wittlin, S., Lada, H., Naylor, M., Santamaria, M., Zhang, J.-G., Starr, R., Hilton, D., Alexander, W., Ormandy, C., et al. (2001) · Genes & Development · doi:10.1101/gad.880801 · Cited by 107
The role of prolactin and growth hormone in breast cancer
Wennbo, H., & Törnell, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203349 · Cited by 106
Prolactin receptors in human breast cancer cells in long-term tissue culture.
Shiu, R. P. C. (1979) · PubMed · Cited by 105
Berlanga, J. J., Gualillo, O., Buteau, H., Perrot‐Applanat, M., Kelly, P. A., & Edery, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2050 · Cited by 104
Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.
Das, R., & Vonderhaar, B. K. (1996) · PubMed · Cited by 103
Chen, W. Y., Ramamoorthy, P., Chen, N., Sticca, R. P., & Wagner, T. E. (1999) · PubMed · Cited by 102
Prolactin receptor is associated with c-src kinase in rat liver
Berlanga, J. J., Vara, J. Á. F., Martín-Pérez, J., & García-Ruiz, J. P. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.11.8584023 · Cited by 101
Dominant Negative and Cooperative Effects of Mutant Forms of Prolactin Receptor
Perrot‐Applanat, M., Gualillo, O., Pezet, A., Vincent, V., Edery, M., & Kelly, P. A. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1020 · Cited by 100
Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation
Rycyzyn, M. A., Reilly, S. C., O’Malley, K. A., & Clevenger, C. V. (2000) · Molecular Endocrinology · doi:10.1210/me.14.8.1175 · Cited by 100
Self-citationO’Neal, K. D., & Yu‐Lee, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47161-x · Cited by 98
Pezet, A., Ferrag, F., Kelly, P. A., & Edery, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25043 · Cited by 98
PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells
Schroeder, M. D., Symowicz, J., & Schuler, L. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0762 · Cited by 97
Self-citationClevenger, C. V., Thickman, K. R., Ngo, W., Chang, W., Takayama, S.-I. J., & Reed, J. C. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.5.9925 · Cited by 97
Self-citationThe Role of Stat3 in Apoptosis and Mammary Gland Involution
Chapman, R. S., Lourenco, P. C., Tonner, E., Flint, D., Selbert, S., Takeda, K., Akira, S., Clarke, A. R., & Watson, C. J. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46832-8_16 · Cited by 96
Shillingford, J. M., Miyoshi, K., Robinson, G. W., Grimm, S. L., Rosen, J. M., Neubauer, H. J., Pfeffer, K., & Hennighausen, L. G. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0805 · Cited by 92
Kodlin, D., & McCarthy, N. (1978) · Cancer · Cited by 90
D’Angelo, G., Martini, J., Iiri, T., Fantl, W. J., MARTIAL, J. A., & Weiner, R. I. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.5.0280 · Cited by 88
Holtkamp, W., Nagel, G. A., Wander, H., et al. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340307 · Cited by 86
Ormandy, C. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3692 · Cited by 85
Helman, D., Sandowski, Y., Cohen, Y., Matsumoto, A., Yoshimura, A., Merchav, S., & Gertler, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01555-5 · Cited by 83
Phosphatidylinositol 3’ kinase: one of the effectors of Ras
Rodriguez‐Viciana, P., Marte, B. M., Warne, P. H., Downward, J., & Marshall, C. J. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0020 · Cited by 80
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period.
Muti, P. C., Trevisan, M., Micheli, A., Krogh, V., BOLELLI, G., Sciajno, R., & Berrino, F. (1996) · PubMed · Cited by 80
Beuvink, I., Heß, D., Flotow, H., Hofsteenge, J., Groner, B., & Hynes, N. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10247 · Cited by 79
HILL, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90644-9 · Cited by 79
Vonderhaar, B. K. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00017-5 · Cited by 78
Transcription of prolactin gene in milk secretory cells of the rat mammary gland
Steinmetz, R. W., Grant, A. L., & Malven, P. V. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1360271 · Cited by 77
IDENTIFICATION OF PROLACTIN-LIKE PROTEINS SYNTHESIZED BY NORMAL MURINE LYMPHOCYTES
Montgomery, D. W., LeFevre, J. A., Ulrich, E. D., Adamson, C., & Zukoski, C. F. (1990) · Endocrinology · doi:10.1210/endo-127-5-2601 · Cited by 77
Santos, S. C. R., Penard‐Lacronique, V., Bouchaert, I., Monni, R., Bernard, O., Gisselbrecht, S., & Gouilleux, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204308 · Cited by 76
Lipworth, L. P., Hsieh, C.-C., WIDE, L. E., Ekbom, A., Yu, S.-Z., Yu, G.-P., Xu, B., Hellerstein, S. C., Carlström, K., Trichopoulos, D., et al. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690003 · Cited by 73
Effects of soy intake on sex hormone metabolism in premenopausal women
Martini, M. C., Dancisak, B. B., Haggans, C. J., Thomas, W., & Slavin, J. L. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc3402_2 · Cited by 73
Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer
WANG, D. Y., Stavola, B. L. D., Bulbrook, R. D., et al. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.2.214 · Cited by 73
Lee, H., Struman, I., Clapp, C., MARTIAL, J. A., & Weiner, R. I. (1998) · Endocrinology · doi:10.1210/endo.139.9.6194 · Cited by 73
Mammary Epithelial Cells of Lactating Rats Express Prolactin Messenger Ribonucleic Acid1
Kurtz, A., Bristol, L. A., Tóth, B. E., Lazar, E., Takács, L., & Kacsoh, B. Z. (1993) · Biology of Reproduction · doi:10.1095/biolreprod48.5.1095 · Cited by 72
Interleukin-2 Driven Nuclear Translocation of Prolactin in Cloned T-Lymphocytes*
Clevenger, C. V., Sillman, A. L., & Prystowsky, M. B. (1990) · Endocrinology · doi:10.1210/endo-127-6-3151 · Cited by 72
Self-citationDisordered nocturnal prolactin regulation in women with breast cancer.
Malarkey, W. B., Schroeder, L., Stevens, V. C., James, A. G., & Lanese, R. R. (1977) · PubMed · Cited by 72
Pezet, A., Buteau, H., Kelly, P. A., & Edery, M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00063-4 · Cited by 70
Prolactin and breast cancer risk
Ingram, D. M., Nottage, E., & Roberts, A. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb126153.x · Cited by 68
Han, Y., Watling, D., Rogers, N. C., & Stark, G. R. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.8.9952 · Cited by 67
MATCHED-PAIRS STUDY OF RESERPINE USE AND BREAST CANCER
LASKA, E. M., Meisner, M., Siegel, C., Fischer, S. M., & WANDERLING, J. A. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92731-2 · Cited by 65
Olazabal, I. M., Muñoz, J., Ogueta, S., Obregón, E., & Garcı́a-Ruiz, J. P. (2000) · Molecular Endocrinology · doi:10.1210/me.14.4.564 · Cited by 65
Effects of controllable vs. uncontrollable chronic stress on stress-responsive plasma hormones
Kant, G. J., Bauman, R. A., Anderson, S. M., & Mougey, E. H. (1992) · Physiology & Behavior · doi:10.1016/0031-9384(92)90323-t · Cited by 64
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescencein situ hybridization
Moch, H., Sauter, G., Gasser, T. C., Bubendorf, L., Richter, J., Presti, J. C., Waldman, F. M., & Mihatsch, M. J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199804)184:4<396::aid-path1259>3.0.co;2-g · Cited by 64
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
Goffin, V., Touraine, P. A., Pichard, C., Bernichtein, S., & Kelly, P. A. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00023-4 · Cited by 63
Cited by
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
The Nurses׳ Health Study: lifestyle and health among women
Colditz, G. A., & Hankinson, S. E. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1608 · Cited by 590
Self-citationFatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
What Can We Learn from Rodents about Prolactin in Humans?
Ben-Jonathan, N., LaPensee, C. R., & LaPensee, E. W. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0017 · Cited by 523
Metadata
- Authors
- Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-02-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-27
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2023523424
- Cited by
- 545
- References
- 251
- FWCI
- 20.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.